Insulin Resistance is Associated with High Plasma Ouabain-like Immunoreactivity Concentration in NIDDM

Overview

Journal Diabetologia

Specialty Endocrinology

Date 1995 Jul 1

PMID 7556980

Citations 1

Authors

T Wasada

H Kuroki

M Naruse

H Arii

A Maruyama

K Katsumori

S Saito

Y Watanabe

K Naruse

H Demura

Affiliations

Soon will be listed here.

Abstract

The aim of the present study was to elucidate the pathophysiologic significance of circulating ouabain as a link between insulin resistance (IR) and hypertension (HT) in NIDDM. Euglycaemic (4.5 mmol/l) hyperinsulinaemic (360-580 pmol/l) clamping was performed using an artificial endocrine pancreas. Plasma ouabain-like immunoreactivity (OLI) was determined by radioimmunoassay using a highly specific antibody to ouabain. HT was defined as systolic blood pressure > 140 mm Hg and/or diastolic > 90 mm Hg or being treated with antihypertensive agents. The values (mean +/- SEM) of glucose infusion rate (GIR) and plasma OLI were compared among the four groups classified using IR and HT as factors. Group I (IR-/HT-, n = 15): GIR 7.20 +/- 0.36 mg.kg-1.min-1, OLI 130.8 +/- 20.9 pmol/l, which was not different from that in eight normal control subjects (7.69 +/- 0.40 mg.kg-1.min-1 and 142.6 +/- 32.3 pmol/l, respectively); Group II (IR-/HT+, n = 13): 5.89 +/- 0.36 mg.kg-1.min-1, 172.5 +/- 35.0 pmol/l; Group III (IR+/HT-, n = 14) 1.91 +/- 0.28 mg.kg-1.min-1, 576.6 +/- 161.5 pmol/l (p < 0.01 vs Group I and II); Group IV (IR+/HT+, n = 15) 1.79 +/- 0.22 mg.kg-1.min-1, 703.1 +/- 170.1 pmol/l (p < 0.01 vs Group I and II), respectively. Six of 57 NIDDM patients studied exhibited very high (> 1500 pmol/l) plasma OLI concentrations, showed marked insulin resistance and were all hypertensive. When analysed as a whole, plasma OLI was negatively correlated with GIR (p < 0.001), but was not correlated with arterial blood pressure.(ABSTRACT TRUNCATED AT 250 WORDS)

Citing Articles

The Gly1057Asp polymorphism in IRS-2 interacts with obesity to affect beta cell function.

Stefan N, Fritsche A, Machicao F, Tschritter O, Haring H, Stumvoll M Diabetologia. 2004; 47(4):759-61.

PMID: 15298357 DOI: 10.1007/s00125-003-1302-6.

References

OHare J, Ferriss J, Brady D, Twomey B, OSullivan D . Exchangeable sodium and renin in hypertensive diabetic patients with and without nephropathy. Hypertension. 1985; 7(6 Pt 2):II43-8. DOI: 10.1161/01.hyp.7.6_pt_2.ii43. View

Hamlyn J, Blaustein M, Bova S, DUCHARME D, Harris D, Mandel F . Identification and characterization of a ouabain-like compound from human plasma. Proc Natl Acad Sci U S A. 1991; 88(14):6259-63. PMC: 52062. DOI: 10.1073/pnas.88.14.6259. View

Doria A, Fioretto P, Avogaro A, Carraro A, Morocutti A, Trevisan R . Insulin resistance is associated with high sodium-lithium countertransport in essential hypertension. Am J Physiol. 1991; 261(6 Pt 1):E684-91. DOI: 10.1152/ajpendo.1991.261.6.E684. View

Feldt-Rasmussen B, Mathiesen E, Deckert T, Giese J, Christensen N, Nielsen M . Central role for sodium in the pathogenesis of blood pressure changes independent of angiotensin, aldosterone and catecholamines in type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 1987; 30(8):610-7. DOI: 10.1007/BF00277316. View

Blaustein M, Ashida T, Goldman W, Wier W, Hamlyn J . Sodium/calcium exchange in vascular smooth muscle: a link between sodium metabolism and hypertension. Ann N Y Acad Sci. 1986; 488:199-216. DOI: 10.1111/j.1749-6632.1986.tb46559.x. View

Halkin H, Modan M, Shefi M, Almog S . Altered erythrocyte and plasma sodium and potassium in hypertension, a facet of hyperinsulinemia. Hypertension. 1988; 11(1):71-7. DOI: 10.1161/01.hyp.11.1.71. View

Garay R, Dagher G, Pernollet M, Devynck M, Meyer P . Inherited defect in a Na+, K-co-transport system in erythrocytes from essential hypertensive patients. Nature. 1980; 284(5753):281-3. DOI: 10.1038/284281a0. View

Cohen M, Dasmahapatra A, Shapiro E . Reduced glomerular sodium/potassium adenosine triphosphatase activity in acute streptozocin diabetes and its prevention by oral sorbinil. Diabetes. 1985; 34(11):1071-4. DOI: 10.2337/diab.34.11.1071. View

Hamlyn J, Manunta P . Ouabain, digitalis-like factors and hypertension. J Hypertens Suppl. 1992; 10(7):S99-111. View

10.

DeFronzo R . The effect of insulin on renal sodium metabolism. A review with clinical implications. Diabetologia. 1981; 21(3):165-71. DOI: 10.1007/BF00252649. View

11.

Gruber K, Whitaker J, BUCKALEW Jr V . Endogenous digitalis-like substance in plasma of volume-expanded dogs. Nature. 1980; 287(5784):743-5. DOI: 10.1038/287743a0. View

12.

Blaustein M . Physiological effects of endogenous ouabain: control of intracellular Ca2+ stores and cell responsiveness. Am J Physiol. 1993; 264(6 Pt 1):C1367-87. DOI: 10.1152/ajpcell.1993.264.6.C1367. View

13.

Hilton P . Cellular sodium transport in essential hypertension. N Engl J Med. 1986; 314(4):222-9. DOI: 10.1056/NEJM198601233140407. View

14.

Mathews W, DUCHARME D, Hamlyn J, Harris D, Mandel F, Clark M . Mass spectral characterization of an endogenous digitalislike factor from human plasma. Hypertension. 1991; 17(6 Pt 2):930-5. DOI: 10.1161/01.hyp.17.6.930. View

15.

Haddy F, PAMNANI M . Evidence for a circulating endogenous Na+-K+ pump inhibitor in low-renin hypertension. Fed Proc. 1985; 44(12):2789-94. View

16.

Sowers J, Khoury S, Standley P, Zemel P, Zemel M . Mechanisms of hypertension in diabetes. Am J Hypertens. 1991; 4(2 Pt 1):177-82. DOI: 10.1093/ajh/4.2.177. View

17.

Andronico G, Mule G, Mangano M, Piazza G, Donatelli M, Cerasola G . Insulin resistance and endogenous digoxin-like factor in obese hypertensive patients with glucose intolerance. Acta Diabetol. 1992; 28(3-4):203-5. DOI: 10.1007/BF00778999. View

18.

de Chatel R, Weidmann P, Flammer J, ZIEGLER W, Vetter W, REUBI F . Sodium, renin, aldosterone, catecholamines, and blood pressure in diabetes mellitus. Kidney Int. 1977; 12(6):412-21. DOI: 10.1038/ki.1977.132. View

19.

de Luise M, Blackburn G, Flier J . Reduced activity of the red-cell sodium-potassium pump in human obesity. N Engl J Med. 1980; 303(18):1017-22. DOI: 10.1056/NEJM198010303031801. View

20.

Modan M, Halkin H, Almog S, Lusky A, Eshkol A, Shefi M . Hyperinsulinemia. A link between hypertension obesity and glucose intolerance. J Clin Invest. 1985; 75(3):809-17. PMC: 423608. DOI: 10.1172/JCI111776. View